Farallon Capital Management »

Elevation Oncology shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.0M 3.5M 0.56
2024-09-30 $2.1M 3.5M 0.60
2024-06-30 $9.7M 3.6M 2.70
2024-03-31 $20M 3.9M 5.13

More positions owned by Farallon Capital Management

Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP)
Aon Shs Cl A (AON)
Exelixis (EXEL)
Amazon (AMZN)
Natera (NTRA)
Revolution Medicines (RVMD)
UnitedHealth (UNH)
Thermo Fisher Scientific (TMO)
Hims & Hers Health Com Cl A (HIMS)
Walt Disney Company (DIS)
salesforce (CRM)
Autodesk (ADSK)

View all positions for Farallon Capital Management

Top funds holding Elevation Oncology

Morgan Stanley
Advisor Group Holdings

View all funds holding Elevation Oncology